User profiles for Yingchi Yang
yingchi yangBeijing Friendship Hospital; Capital Medical University Verified email at ccmu.edu.cn Cited by 495 |
UBR5 contributes to colorectal cancer progression by destabilizing the tumor suppressor ECRG4
J Wang, X Zhao, L Jin, G Wu, Y Yang - Digestive diseases and sciences, 2017 - Springer
Background The E3 ligase UBR5 is aberrantly expressed in diverse types of cancer. However,
its expression pattern and biological function in colorectal cancer (CRC) remain unclear. …
its expression pattern and biological function in colorectal cancer (CRC) remain unclear. …
[HTML][HTML] Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer
D Wang, Y Yang, L Jin, J Wang, X Zhao, G Wu… - Journal of …, 2019 - ncbi.nlm.nih.gov
Background: It is urgent to develop robust prognostic biomarkers for non-metastatic colorectal
cancer (CRC) patients undergoing surgery. The current study aimed to explore and …
cancer (CRC) patients undergoing surgery. The current study aimed to explore and …
[HTML][HTML] The MiR-495/Annexin A3/P53 axis inhibits the invasion and EMT of colorectal cancer cells
…, J Wang, T Wang, Y Li, X Zhao, G Wu, Y Yang… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: More and more reports have shown that the dysregulation of miRNAs can
contribute to the progression and metastasis of human cancers. Many studies have shown …
contribute to the progression and metastasis of human cancers. Many studies have shown …
Inhibition of neuroactive ligand–receptor interaction pathway can enhance immunotherapy response in colon cancer: an in silico study
Y Yang, J Li, C Jing, Y Zhai, Z Bai, Y Yang… - Expert Review of …, 2023 - Taylor & Francis
Background The potential mechanism underlying the association between Homologous
recombination deficiency (HRD) and immunotherapy in colon cancer has not been investigated. …
recombination deficiency (HRD) and immunotherapy in colon cancer has not been investigated. …
Electroacupuncture vs sham electroacupuncture in the treatment of postoperative ileus after laparoscopic surgery for colorectal cancer: a multicenter, randomized …
…, ZK Li, H Zhou, NN Yang, LQ Wang, YC Yang… - JAMA …, 2023 - jamanetwork.com
Importance Despite the adoption of the optimized Enhanced Recovery After Surgery (ERAS)
protocol, postoperative ileus (POI) severely impairs recovery after colorectal resection and …
protocol, postoperative ileus (POI) severely impairs recovery after colorectal resection and …
[HTML][HTML] Sarcobesity, but not visceral fat, is an independent risk factor for complications after radical resection of colorectal cancer
…, K Pang, M Tian, X Gu, H Lin, X Yang, Y Yang… - Frontiers in …, 2023 - frontiersin.org
Background The influence of body composition on the outcome of colorectal cancer surgery
is controversial. The aim of this study was to evaluate the effects of visceral obesity and …
is controversial. The aim of this study was to evaluate the effects of visceral obesity and …
Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer
Purpose The aim of this study was to investigate the prognostic value of the combination of
microsatellite instability (MSI) and BRAF V600E mutation in colorectal cancer (CRC). …
microsatellite instability (MSI) and BRAF V600E mutation in colorectal cancer (CRC). …
[HTML][HTML] BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis
…, W Deng, Y Zhao, J Guo, Y Yang, Z Zhang, Y Yang - BMC cancer, 2023 - Springer
Background Breast cancer susceptibility gene (BRCA) mutation carriers are at an increased
risk for breast, ovarian, prostate and pancreatic cancers. However, the role of BRCA is …
risk for breast, ovarian, prostate and pancreatic cancers. However, the role of BRCA is …
Associations of postoperative complications assessed by clavien–dindo classification and comprehensive complication index with long-term overall survival in elderly …
D Wang, J Zhang, Z Bai, Y Yang, T Wang… - … interventions in aging, 2020 - Taylor & Francis
… Yingchi Yang1 Department of General Surgery, Beijing Friendship Hospital, Capital Medical
… study are available from the corresponding author, Yingchi Yang, upon reasonable request. …
… study are available from the corresponding author, Yingchi Yang, upon reasonable request. …
Circulating tumor DNA detectable in early-and late-stage colorectal cancer patients
YC Yang, D Wang, L Jin, HW Yao, JH Zhang… - Bioscience …, 2018 - portlandpress.com
Characterization, diagnosis, and treatment of colorectal cancers (CRC) is difficult due to
limited biopsy information, impracticality of repeated biopsies, and cancer biomarker fallibility. …
limited biopsy information, impracticality of repeated biopsies, and cancer biomarker fallibility. …